Veijo Salo
About me
I am a medical doctor by training and a cell biologist by passion. My research centers on one fundamental question: how do cells organize and control lipid metabolism?
During my PhD in lipid cell biology, I uncovered mechanisms that regulate how cells handle and distribute lipids. I developed innovative tools to trace lipid flux in living cells and engineered systems to precisely manipulate key regulators, revealing how membrane proteins define where lipid-related processes occur. For my postdoctoral work at EMBL Heidelberg, I deliberately stepped into structural biology to understand these processes at a deeper level. I became an expert in in situ cryo-electron tomography, a technique that allows us to visualize molecular machinery directly inside intact cells. To overcome limitations in nanoscale protein localization, we developed genetically encoded nanoparticles (GEMs), expanding cryo-ET to cellular phenomena where prior structural knowledge is limited.
Using these approaches, I have begun to reveal how key lipid regulators are organized at the nanoscale within cells, providing new insight into how membrane architecture shapes organelle biogenesis. Today, my laboratory at Karolinska Institutet integrates cell biology and in-cell structural biology to understand how liver cells balance lipid storage and lipid secretion. This balance is central to metabolic health, and its disruption contributes to common diseases such as fatty liver disease and cardiovascular disorders.
Research
Lipid flux and cellular self-organization
Lipids are fundamental building blocks of cellular life. Beyond serving as energy stores, they define membrane identity, shape organelles, and regulate signaling and metabolic adaptation. Yet many core principles remain unresolved. How do cells decide when to store lipids versus mobilize or secrete them? How do membranes remodel to generate new organelles? How do local lipid environments influence protein activity and cellular fate
My laboratory investigates how lipid flux is organized across scales — from molecular interactions to whole-cell architecture. We combine advanced fluorescence imaging, genome engineering, and in-cell structural biology to visualize membrane remodeling directly inside intact cells. A central focus is understanding how nanoscale membrane organization encodes metabolic decisions, particularly in liver cells where lipid storage and secretion must be precisely balanced to maintain systemic health. Disruption of these processes contributes to common diseases including fatty liver disease and cardiovascular disorders.
By integrating cell biology with cryo-correlative microscopy and in situ cryo-electron tomography, we aim to uncover the molecular logic that governs lipid flux in health and disease.
Join the lab
We welcome curious and motivated researchers who are excited about membrane biology, metabolism, and advanced imaging.
If you are interested in joining the lab, feel free to get in touch.More about our reserach can be found on our lab website.
Grants
- Nanoscale architecture of hepatic neutral lipid flux in the endoplasmic reticulumSwedish Society for Medical Research1 April 2026 - 31 March 2030
- Swedish Research Council1 January 2026 - 31 December 2029The balance of intracellular neutral lipid (NL) flux in hepatocytes is critical for metabolic health: excessive lipid deposition in intracellular lipid droplets (LDs) leads to fatty liver disease, while excessive secretion of NLs within very-low-density lipoproteins (VLDLs) drives atherosclerosis. Despite these opposing outcomes, both LDs and VLDLs originate from the endoplasmic reticulum (ER) bilayer, yet the nanoscale coordination of their assembly remains poorly understood. This project seeks to resolve a fundamental question: how is NL fate determined in the ER?By integrating cutting-edge cell biology, cryo-correlative light and electron tomography (cryo-CLEM ET) with our newly developed localization tags, and lipid biophysics, I will construct a dynamic 4D model of LD and VLDL biogenesis within specialized ER subdomains. This research will uncover the intricate interplay between LD and VLDL assembly, elucidate the molecular mechanisms driving seipin conformational changes during LD formation, and reveal how lipid composition and biophysical properties define ER subdomains for NL partitioning.Through an interdisciplinary approach that bridges structural biology, live-cell imaging, and computational modeling, this project will provide an unprecedented molecular blueprint of hepatic NL flux. These insights will not only advance our fundamental understanding of lipid metabolism but also lay the groundwork for future therapeutic strategies targeting metabolic disorders.
Employments
- Assistant Professor, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2026-2031
- Academy Reserach Fellow, Institute of Biotechnology, University of Helsinki, 2026-2029
Visiting research fellowships
- Postdoctoral researcher in Julia Mahamid group, EMBL Heidelberg, European Molecular Biology Laboratory, 2020-2026
